PD-L1 Antikörper (Extracellular Domain)
Kurzübersicht für PD-L1 Antikörper (Extracellular Domain) (ABIN6383847)
Target
Alle PD-L1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 39-191, Extracellular Domain
-
Verwendungszweck
- PD-L1
-
Aufreinigung
- By Protein A from bioreactor concentrate
-
Immunogen
- Recombinant fragment around aa 39-191 of human CD274 protein (exact sequence is proprietary)
-
Isotyp
- IgG2b kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
HEK293, HepG2, heart, placenta, spleen, tonsil, carcinomas.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg IgG/mL in PBS, 0.05 % azide
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Informationen zur Lagerung
- For long term storage, keep small aliquots at -20°C or -80°C and keep one aliquot at 4°C for daily experimentations. Azide will preserve antibody at 4°C for 6-12 months, when kept away from direct sun light.
-
-
- PD-L1 (CD274 (PD-L1))
-
Andere Bezeichnung
- CD274
-
Hintergrund
- CD274 Molecule, B7-H, B7H1, B7-H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, Programmed death ligand 1, B7 homolog 1, CD_antigen: CD274
-
Gen-ID
- 29126
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Target
-